Kimberly-Clark Says Rogaine Sales Are Up 30% This Year and Points to GLP-1 Hair Loss as a Possible Reason
Kimberly-Clark, which has completed its acquisition of Tylenol and Band-Aid owner Kenvue, reported a 30% year-to-date increase in sales of Rogaine hair-loss medication, CNBC reported on November 5. CEO Michael Hsu suggested the growth could be driven by adoption of GLP-1 drugs, which carry hair loss as a potential side effect. He offered it as a possible explanation, not a measured one.